Profil

Marechal Louis

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Biochimie métabolique et moléculaire

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service du Secrétariat des études de la Faculté de Médecine et de Pharmacie

Université de Mons - UMONS > Faculté de Médecine, Pharmacie et Sciences Biomédicales > Service du Secrétariat des études de la Faculté de Médecine, Pharmacie et Sciences Biomédicales

ORCID
0009-0003-9626-0527
Main Referenced Co-authors
DECARNONCLE, Morgane  (9)
DECLEVES, Anne-Emilie  (9)
JUSZCZAK, Florian  (8)
MARLIER, Hélène  (6)
Pierre, Louise  (6)
Main Referenced Keywords
obesity (3); AMPK (2); Lipotoxicity (2); Lysosome (2); Chronic Kidney Disease (1);
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (5)
Endocrinology, metabolism & nutrition (4)
Urology & nephrology (3)
Anatomy (cytology, histology, embryology...) & physiology (3)

Publications (total 9)

The most downloaded
114 downloads
Decarnoncle, M., Marlier, H., Lhoir, F., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Decroo, C., Coppée, F., Tassin, A., Wattiez, R., & Decleves, A.-E. (01 December 2023). Organokine impact in obesity induced chronic kidney disease [Poster presentation]. GENDER DIFFERENCES IN RENAL DISEASE FOCUS ON DIABETES AND OBESITY, Garachico, Spain. https://hdl.handle.net/20.500.12907/46802

The most cited

1 citations (OpenAlex)

Decarnoncle, M.* , Pierre, L.* , Thirion, M., Marlier, H., Marechal, L., Rouzé, P., Jadot, I., Arnould, T., Decleves, A.-E., & Juszczak, F. (09 April 2026). Effects of NAD⁺ repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity. Scientific Reports, 16 (1). doi:10.1038/s41598-026-46173-x https://hdl.handle.net/20.500.12907/56255

Marechal, L., Decarnoncle, M., Pruvost, D., Marlier, H., Arnould, T., & Decleves, A.-E. (11 April 2026). The AMPK plays a crucial role in the protection of renal function upon lipotoxic injuries [Poster presentation]. European Renal Cell Study Group 2026, Nogent-Sur-Marne, France.
Editorial reviewed

Decarnoncle, M.* , Pierre, L.* , Thirion, M., Marlier, H., Marechal, L., Rouzé, P., Jadot, I., Arnould, T., Decleves, A.-E., & Juszczak, F. (09 April 2026). Effects of NAD⁺ repletion with Nicotinamide riboside on obesity-induced chronic kidney disease and renal cell lipotoxicity. Scientific Reports, 16 (1). doi:10.1038/s41598-026-46173-x
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Decarnoncle, M., Marechal, L., Pierre, L., Marlier, H., Francois, L., Pruvost, D., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (28 November 2025). Impact of irisin, an exercise mimetic, in renal lipotoxicity [Poster presentation]. EXERCISE AND DIET IN OBESITY, DIABETES AND RENAL DISEASE, Garachico, Spain.
Peer reviewed

Decarnoncle, M., Marechal, L., Pierre, L., Marlier, H., François, L., Pruvost, D., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (21 September 2025). Impact of irisin, an exercise mimetic, in renal lipotoxicity [Poster presentation]. EMBO workshop : Lipid Droplets: Cell-Biological Control of Metabolism, Sant Feliu de Guixols, Spain.
Peer reviewed

Decarnoncle, M., Marechal, L., Pierre, L., Marlier, H., François, L., Pruvost, D., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (25 April 2025). Impact of irisin, an exercise mimetic, in chronic kidney disease induced by obesity [Paper presentation]. PhysPhar.
Peer reviewed

Marechal, L., Pierre, L., Juszczak, F., Decarnoncle, M., Pruvost, D., Delmotte, V., Ledoux, B., Bultot, L., Bertrand, L., Bonen, M., Renard, P., Arnould, T.* , & Decleves, A.-E.*. (11 March 2025). AMPK-lysosome axis : a cornerstone of PTEC function and (de)differentiation upon lipotoxicity [Poster presentation]. Metabolism Day 2025, Copenhagen, Denmark.
Peer reviewed
* These authors have contributed equally to this work.

Decarnoncle, M., Pierre, L., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (05 April 2024). Impact of myokines on AMPK activity in chronic kidney disease induced by obesity [Paper presentation]. The meeting ERCSG 2024, Broxbourne, United Kingdom.
Peer reviewed

Decarnoncle, M., Marlier, H., Lhoir, F., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Decroo, C., Coppée, F., Tassin, A., Wattiez, R., & Decleves, A.-E. (01 December 2023). Organokine impact in obesity induced chronic kidney disease [Poster presentation]. GENDER DIFFERENCES IN RENAL DISEASE FOCUS ON DIABETES AND OBESITY, Garachico, Spain.
Peer reviewed

Decarnoncle, M., Pierre, L., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (29 March 2023). Impact of myokines on AMPK activity in obesity-induced chronic kidney disease [Paper presentation]. Diabète de type 1 & Exercice physique : de la gestion des risques aux bénéfices pour la santé, Loos, France.

Contact ORBi UMONS